SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesequity

Delcath Systems, Inc. (DCTH) News

Follow Delcath Systems, Inc. (DCTH) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 6 public stories across 4 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol DCTH Asset equity Sector Markets 90 days 6 Last 18.8 Updated Nov 09, 2026, 01:15 PM UTC Open live news feed Open DCTH chart & news
M Delcath Systems Q3 Revenue Beats on Hepzato Growth EQUITY | Nov 09, 2026, 01:15 PM UTC M Delcath Systems Q3 Revenue USD 35.102 Million; Net Income USD 6.952 Million Reuters reports Q3 revenue of USD 35.102 million versus an IBES estimate of USD 26 million, and net income of USD 6.952 million. EQUITY | Nov 09, 2026, 01:03 PM UTC H Delcath Systems Q2 2026 Earnings Call Transcript Delcath Systems (NASDAQ: DCTH ) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. APIs provide real-time access to earnings cal LIVE | Oct 06, 2026, 09:31 AM UTC L Delcath Systems Announces Inducement Grants Under Nasdaq Listing Rule Delcath Systems Inc NASDAQ:DCTH NEWS | Sep 11, 2026, 08:16 PM UTC L Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Delcath Systems, Inc. (Nasdaq: DCTH) (the “Company” or “Delcath”), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announces that the Company granted equity awa NEWS | Sep 11, 2026, 08:01 PM UTC L Delcath Systems to Participate in Upcoming Investor Conferences Delcath Systems to Participate in Upcoming Investor Conferences EQUITY | Aug 31, 2026, 08:01 PM UTC